Module code: BMD383
Credits: 15.0
Semester: SEM2
Timetable:
Lecture- Semester 2: Weeks 1, 2, 3, 4, 5, 6, 8, 9, 10, 11, 12: Friday 2 pm - 4 pm
- Semester 2: Weeks 16: Thursday 2 pm - 3 pm
Contact: Dr Angus Cameron
Overlap: None
Prerequisite: BMD181
This module will build on basic information on the pathological processes and cancer biology provided in other modules to provide an in-depth analysis of the tools available to analyse heterogeneity in disease (gene expression arrays, SNP analysis, next generation sequencing), and how these can be used to stratify disease and then exploited to develop individualised treatment. It will examine strategies being developed to refine treatment programmes and also investigate how such analyses can be used to predict risk and so develop preventive strategies. It will be lecture based, delivered by experts in the field, and supplemented with seminar sessions describing approaches to analysing data and interrogating the literature.
Connected course(s): UDF DATA
Assessment: 80.0% Examination, 20.0% Coursework
Level: 6
